Industry InsightsApril 10, 20230Norcliffe Capital has closed its pre-series A investment of £3.64million into SMi Drug Discovery

Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.
What are the key risks?
If you are interested in learning more about how to protect yourself, visit the FCA’s website here.